Therapeutic Epinastine containing pharmaceutical compositions skin diseases

The present invention relates to novel pharmaceutical compositions for the treatment of skin disorders. The composition may comprise one or more sulfur containing as a donor with a biological activity of epinastine or a pharmaceutically acceptable salt thereof, and -S- or -SH groups of antihistaminic effective amount as a pharmaceutically active compound amino acid or peptide, at least one vitamin B group, at least one vitamin having antioxidant properties, and anti-inflammatory - contains at least one compound selected from the group consisting of an effective amount of anti-inflammatory compounds. The composition may also contain additives which can be pharmaceutically acceptable.